Nucleus Capital
VC Fund
Berlin, Germany
Nucleus Capital is a new venture capital firm supporting purpose-driven founders. We profoundly believe that entrepreneurial innovation is necessary to tackle global threats to human and planetary health. We partner with entrepreneurs at the nucleus of their journey, investing at the Pre/Seed stage and are focussed on Synthetic &Computational Biology, Food- and Climate Technology.
- Total investments:
- 28
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Nucleus Capital invests in
Stages Nucleus Capital invests in
Countries Nucleus Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $3M–$7.4M
- Pre-Seed
- $125k–$3M
Investment Focus
Industry
- Biotechnology 9 (32%)
- Food and Beverage 9 (32%)
- Life Science 4 (14%)
- Information Technology 4 (14%)
- Software 3 (11%)
Stage
- Pre-Seed 15 (54%)
- Seed 11 (39%)
- Series A 1 (4%)
Country
- Germany 10 (36%)
- United Kingdom 5 (18%)
- United States 4 (14%)
- The Netherlands 2 (7%)
- Denmark 1 (4%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
Isabella Fandrych
Co-Founder
|
Co-Founder | Total investments: 2 | Find email | |
Martin Weber
Investor
|
Investor | Total investments: 4 | Find email | |
Maximilian Schwarz
Founder
|
Founder | Total investments: 3 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Biomanufacturing Scale-Up Solution | $3.1M / Pre-Seed / Feb 01, 2025 | ||
| Ucaneo is an environmental services company that develops carbon removal technology designed to capture carbon dioxide from the air. | $7.4M / Seed / Sep 10, 2024 | ||
| Planet A Foods specializes in the production of cocoa-free chocolate. The company strives to produce food locally, with minimal impact on land and resources, and reduce carbon emissions globally. | $15.4M / Series A / Feb 01, 2024 | ||
| Trilobio was created to improve synthetic biology and life science research processes by building robotic lab automation modules coupled with an "app store" to package and distribute lab protocols as code. The goal is to deploy fully automated labs that dramatically improve data quality and reproducibility. | $3M / Seed / Nov 29, 2023 | ||
| Biomia is a synthetic biology company developing plant-derived natural products for unmet medical needs in pain, addiction, and depression. | $3M / Pre-Seed / Sep 26, 2023 | ||
| A farmless fermentation platform has the potential to create an entirely new food repertoire, producing proteins, carbohydrates, beneficial fats, vitamins, and minerals from the ground up," explained Oner. "We are creating a new interface between food and electricity by domesticating microbes chosen for their food properties and abilityto grow on renewable energy-based feedstocks. | $1.3M / Pre-Seed / May 10, 2023 | ||
| At Infyos we are building a future where every battery is sustainable. Our digital platform helps battery and car makers manage and improve their company and supply chain sustainability. We help companies get ahead of their customer and regulation requirement deadlines and on an achievable pathway towards sustainability. Knowing what improvementsto implement is challenging in this complex and quickly evolving landscape. We are combining our deep domain knowledge with our leading software to bring sustainability expertise to the next generation of battery players. We're proud to be backed by Pale blue dot, Nucleus Capital, Intercalation, Carbon13 and other brilliant undisclosed climate investors and angels. | $1M / Pre-Seed / Apr 25, 2023 | ||
| We’re helping the oil and gas industry to reduce greenhouse gas emissions by building the industry’s operating system to find, fix, and report methane leaks. | $1.4M / Pre-Seed / Apr 01, 2023 | ||
| Repath Identifies and manages climate risks with SaaS solution. The platform for climate risk and adaptation is a location-specific, user-friendly, fully functional automated SaaS solution that would allow the company to forecast the future physical climate risks, comprehend the particulars vulnerabilities of the assets, as well as the necessarymeasures of adaptation to mitigate the identified dangers. Its customers can access the translated climate data into easy-to-understand aggregated results via repath´s platform or via API. | $1.3M / Pre-Seed / Dec 13, 2022 | ||
| Concert Bio helps growers harness the vast potential of their plant microbiome. | $1.8M / Pre-Seed / Aug 01, 2022 | ||
| See all 28 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Featured in Investor Lists
Recommended lists
FAQ
What does Nucleus Capital invest in?
Nucleus Capital invests primarily in Biotechnology, Food and Beverage and Life Science startups, most often at Pre-Seed and Seed stage. Most of the 28 investments tracked by Shizune back companies in Germany. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Nucleus Capital's check size?
Nucleus Capital typically joins rounds of $3M–$7.4M at Seed and $125k–$3M at Pre-Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Nucleus Capital participates in.
How do I contact Nucleus Capital?
Public channels for Nucleus Capital include LinkedIn and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Nucleus Capital?
The team at Nucleus Capital includes Isabella Fandrych (Co-Founder), Martin Weber (Investor) and Maximilian Schwarz (Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
